1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 
Patient characteristics for each molecular subtype
IDHmut-CodelIDHmut-NoncodelIDHwt
Total patientsa104 (34.0%)129 (42.2%)73 (23.9%)
Female sex58 (55.8%)61 (47.3%)35 (47.9%)
Ageb48 (17–74)35 (17–70)57 (19–76)
WHO grade
 II72 (69.2%)83 (64.3%)34 (46.6%)
 III32 (30.8%)46 (35.7%)39 (53.3%)
  • ↵a Data are listed as count (percentage of total cohort).
  • ↵b Data are listed as median (range). Other data are listed as count (percentage of cases within given molecular subtype).